Biostem Technologies Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BSEM Over the counter 2834 https://www.biostemtechnologies.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Biostem Technologies Inc

BioStem Technologies Reports Record Breaking Second Quarter Sales - Aug 25th, 2021 3:15 pm
BioStem Technologies, Inc., Announces the Engagement of Biologics Consulting To Support FDA Strategies and Submissions. - Jul 27th, 2021 1:00 pm
BioStem Technologies, Inc. Awarded Q Code for VENDAJE® Product Line From CMS. - Jul 23rd, 2021 1:00 pm
BioStem Technologies Announces Filing of 2021 First Quarter Financial Reports - May 24th, 2021 3:34 pm
BioStem Technologies, Inc., Announces the Addition of Three Key Scientific Advisory Board Members - Apr 20th, 2021 1:00 pm
BioStem Technologies, Inc. Announces Launch of National Sales Force Expansion - Apr 15th, 2021 1:00 pm
BioStem Technologies, Inc. Reports Financial Results for Fourth Quarter and Fiscal Year 2020 - Apr 5th, 2021 1:00 pm
BioStem Technologies, Inc. Receives TRIP (TRG Rapid Inquiry Program) Response for VENDAJE™ - Mar 25th, 2021 1:00 pm
BioStem Technologies Engages D. Brooks & Associates for 2020 and 2019 Audit - Mar 15th, 2021 1:00 pm
BioStem Technologies, Announces Filing of 2020 Quarterly Reports - Dec 24th, 2020 7:00 pm
BioStem Technologies, Inc. Announces Launch of AEON™ - Oct 27th, 2020 1:00 pm